Adipose-derived stem cell-based treatment for acute liver failure

Area of Science:

• Regenerative Medicine
• Hepatology
• Stem Cell Biology

Background:

• Acute liver failure (ALF) presents limited therapeutic options and a critical shortage of donor livers.
• Stem cell transplantation is emerging as a promising alternative for ALF treatment.
• This study investigates the therapeutic potential of human adipose-derived stem cells (ASCs) for ALF.

Purpose of the Study:

• To evaluate the efficacy of human ASC transplantation in a rat model of ALF.
• To explore the underlying mechanisms of ASC-mediated therapeutic effects in ALF.
• To assess the potential of ASC-derived factors in treating ALF.

Main Methods:

• ALF was induced in Sprague Dawley rats using D-galactosamine injection.
• Rats were treated with human ASCs or PBS via splenic transplantation.
• Hepatic function, histology, survival rates, and ASC fate were assessed; ASC conditional media and lysates were also tested.

Main Results:

• ASC transplantation significantly improved rat viability and liver function compared to controls.
• Histological analysis revealed improved liver morphology with modulated cell proliferation and apoptosis.
• ASCs did not differentiate into hepatocytes within 3 days, but their secreted factors (HGF, VEGF) improved ALF rat survival.

Conclusions:

• Human ASC transplantation demonstrates therapeutic potential for ALF.
• The therapeutic effect is partly mediated by the secretion of growth factors that promote liver regeneration.
• ASC-derived conditional media and lysates also show promise for ALF treatment.